EluNIR Ridaforolimus Eluting Coronary Stent System LUN275R12USRecalls & reported problems
Medinol Ltd. · Class 3 · Implant
All models of EluNIR Ridaforolimus Eluting Coronary Stent System (27)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07290107013604), received between Nov 14, 2018 and Nov 14, 2018 — classified as 1 injury.
The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Burst Container or Vessel1
- Leak/Splash1
Patient problems
- Vascular Dissection1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryNov 14, 2018Burst Container or Vessel; Leak/Splash; Burst Container or Vessel; Leak/Splash
INITIAL CASE DESCRIPTION (RECEIVED FROM CORDIS ON OCT. 23, 2018): DESCRIPTION AS REPORTED: "DR PREDILIATED 90% LESION WITH A SEMI COMPLIANT NEAR OSTIUM OF SVG. PREDILITATION WAS FINE. STENT WAS TAKEN TO LESION, WHEN THE SCRUB TECH TURNED THE INDEFLATOR TWICE, THE BALLOON BURST WITHOUT GOING ANYWHERE CLOSE TO NOMINAL (PERHAPS 2 ATMS. STENT WAS SEVERELY UNDER-DEPLOYED, AND FLOATING ON THE WIRE IN THE SVG. DR WAS ABLE TO REMOVE THE STENT BALLOON AND GO IN WITH AN NC POST DILATATION BALLOON TO OPPOSE THE STENT TO THE WALLS. HE THEN SAW A DISSECTION, TREATED THE DISSECTION WITH A SECOND STENT, AND USED IVUS AT THE END TO ENSURE THAT THE FIRST STENT WAS TRULY OPPOSED. THE PATIENT WAS OK, AND THE RESULT WAS GOOD. HOWEVER; THE STENT BALLOON BURST ALMOST IMMEDIATELY WHEN THE PREDILITATION AND POST DILATATION BALLOONS DID NOT AT ALL, NOR DID THE SECOND ELUNIR THAT THE DOC PLACED" DESCRIPTION SUMMARY: "AS REPORTED, THE PHYSICIAN PRE-DILIATED 90% OF THE LESION WITH A SEMI COMPLIANT BALLOON NEAR THE OSTIUM OF THE SAPHENOUS VEIN GRAFT (SVG). THE ELUNIR (2.75X12 US) STENT WAS TAKEN TO THE LESION; HOWEVER, WHEN THE SCRUB TECH TURNED THE INDEFLATOR TWICE, THE BALLOON BURST AT APPROXIMATELY 2 ATMOSP
Patient problems: Vascular Dissection
MAUDE report 8068214 ↗
Other Coronary Drug-Eluting Stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page